Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

Amgen/AZ confirm brodalumab psoriasis filing in 2015

Drug demonstrates greater effectiveness than J&J’s Stelara

Novartis day

FDA needs more time to review Novartis’ cancer drug

Panobinostat is being investigated for use in multiple myeloma

Takeda names Marc Princen as president of EUCAN

He previously served as a president at Merck

- PMLiVE

Sanofi names CSO Gary Nabel to Ebola role

He will serve as response coordinator for the company’s approach to the outbreak.

- PMLiVE

The potential of regulated wearable technology

New health-tracking technologies are set to be taken seriously as medical devices

- PMLiVE

Novartis partners with NHS on eye service

Launches community programme in Bristol

- PMLiVE

Deaths cause Amgen to drop stomach cancer drug

Increase in patient mortality in patients taking rilotumumab during trial

- PMLiVE

Merck files once-weekly DPP-4 inhibitor in first market

Picks Japan to submit omarigliptin

- PMLiVE

Merck buys rights to NewLink’s Ebola vaccine

Drug is set to enter large phase III study in early 2015

- PMLiVE

UK e-cigarette advert comes under fire

BMA accuses campaign of glamorising smoking

- PMLiVE

MRC Technology and Yabao form Parkinson’s partnership in China

Companies will target specific kinase involved in neurodegeneration

- PMLiVE

Napp names new managing director

Alberto Martinez joins from Mundipharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links